WFDC2
Basic information
Region (hg38): 20:45469753-45481532
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bronchiectasis and nasal polyposis | AR | Allergy/Immunology/Infectious; Pulmonary | The condition involves chronic airway infections resulting in pulmonary and related sequelae, and diagnosis may allow interventions to prevent and treat infections as well as optimize pulmonary function; lung transplant has been described | Allergy/Immunology/Infectious; Obstetric; Pulmonary | 38626355 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (22 variants)
- Bronchiectasis_and_nasal_polyposis (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WFDC2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006103.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 1 | 21 | 2 | 0 |
Highest pathogenic variant AF is 0.00015487835
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WFDC2 | protein_coding | protein_coding | ENST00000372676 | 3 | 11827 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.794 | 0.201 | 103484 | 0 | 1 | 103485 | 0.00000483 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0559 | 69 | 70.3 | 0.981 | 0.00000346 | 800 |
Missense in Polyphen | 20 | 24.233 | 0.82533 | 295 | ||
Synonymous | 0.286 | 27 | 29.0 | 0.932 | 0.00000136 | 240 |
Loss of Function | 2.12 | 0 | 5.23 | 0.00 | 2.24e-7 | 60 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000113 | 0.0000113 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Broad range protease inhibitor. {ECO:0000269|PubMed:23139753}.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- loftool
- 0.397
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.79
Haploinsufficiency Scores
- pHI
- 0.484
- hipred
- N
- hipred_score
- 0.203
- ghis
- 0.570
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Wfdc2
- Phenotype
Gene ontology
- Biological process
- proteolysis;spermatogenesis;negative regulation of endopeptidase activity
- Cellular component
- extracellular space;extracellular exosome
- Molecular function
- endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity;cysteine-type endopeptidase inhibitor activity;aspartic-type endopeptidase inhibitor activity